| Name | Title | Contact Details |
|---|
Millwork Sales Inc is a Orlando, FL-based company in the Manufacturing sector.
Formica Group is a leading provider of branded, designed surfacing solutions for commercial and residential customers worldwide. As the world’s largest manufacturer of High Pressure Laminate (HPL), our international network of design, manufacturing, distribution and sales operations maintains the recognition of Formica as a global brand. The heritage and brand reputation of the Formica Group of companies has been founded on quality, service and innovative product lines. We have developed an unrivaled expertise that ensures products meet the needs of their applications — as well as market demands. Working closely with architects, designers and developers, the company is strategically positioned to offer new products and surfacing solutions that complement current design trends. Our ongoing product design and development process underscores our commitment to innovation. In addition, we provide our homeowner customers with the surfacing materials they need, whether it’s laminate countertops for a kitchen renovation, a vanity top for a bathroom remodel, DIY cabinet refacing, or countless other projects. In May 2007, the Formica Group of companies was acquired by Fletcher Building, one of Australia’s and New Zealand’s largest building companies. The acquisition resulted in the creation of the world’s largest manufacturer of decorative surfaces and high pressure laminate. Formica Group is a global group of companies consisting of Formica Canada, Inc., Formica Corporation, Formica de Mexico S.A. de C.V., Formica IKI Oy, Formica Limited, Formica S.A., Formica S.A.S., Formica Taiwan Corporation, Formica (Thailand) Co., Ltd., Formica (Asia) Ltd., and Homapal GmbH, among others.
The Chelco Group of Companies is a Avenel, NJ-based company in the Manufacturing sector.
Oscar Heyman is a New York, NY-based company in the Manufacturing sector.
Neos Therapeutics is focused on developing, manufacturing and commercializing branded products utilizing our proprietary extended-release drug delivery technology platform, which serves as the basis for our three product candidates being investigated for the treatment of attention deficit hyperactivity disorder (ADHD). Our ADHD product candidates include the following formulations; oral disintegrating tablets (ODT) and liquid suspension. Drug Delivery Platform: Our proprietary extended-release drug delivery platform has enabled us to create new patient- and caregiver-friendly dosage forms of methylphenidate and amphetamine. Formulations: In 2014 alone, 63.1 million prescriptions for medications with ADHD labeling, and principally in extended-release formulations, were written in the United States. The majority of currently available dosage forms for ADHD are tablets and capsules. The two lead Neos Therapeutics product candidates provide a plasma concentration-time profile that is consistent with once daily dosing in an orally disintegrating tablet that disintegrates in the mouth without water. Our goal is to be a leading pharmaceutical company focused on the development, manufacture and commercialization of branded pharmaceutical products that utilize our proprietary extended-release drug delivery technology platform. Neos Therapeutics is a growing, dynamic company that can provide employees with the opportunities and challenges they need to enjoy a rewarding career and make a difference in the lives of others. Our success depends on a motivated team of people collaborating to create quality healthcare products. This requires employees with exceptional leadership skills, flexibility, technical expertise and a commitment to excellence. We offer competitive compensation packages to full-time employees. We seek to attract the right people and provide incentives and career development that can turn employment into opportunity.